Market Tracker

12/19 6:05pm ET

Actavis PLC (NYSE:ACT)

265.39
Data as of Dec 19
 +1.64 / +0.62%
Today’s Change
161.92
Today|||52-Week Range
272.75
+57.97%
Year-to-Date

Today’s Trading

Previous close263.75
Today’s open263.75
Day’s range261.79 - 267.61
Volume3,528,571
Average volume (3 months)3,102,057
Market cap$70.3B
Dividend yield--
Data as of 4:12pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+42.76%
Earnings growth (next 5 years)+20.20%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.85

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.28+0.61%
AGNAllergan+0.45+0.21%
LLYEli Lilly and Co-0.05-0.07%
AZNAstraZeneca-0.42-0.58%
Data as of 4:04pm ET, 12/19/2014

Financials

Next reporting dateFebruary 17, 2015
EPS forecast (this quarter)$3.49
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts